ATE343632T1 - Mutiertes nurr1 gen - Google Patents

Mutiertes nurr1 gen

Info

Publication number
ATE343632T1
ATE343632T1 AT00946672T AT00946672T ATE343632T1 AT E343632 T1 ATE343632 T1 AT E343632T1 AT 00946672 T AT00946672 T AT 00946672T AT 00946672 T AT00946672 T AT 00946672T AT E343632 T1 ATE343632 T1 AT E343632T1
Authority
AT
Austria
Prior art keywords
relates
well
gene
mutated
treatment
Prior art date
Application number
AT00946672T
Other languages
English (en)
Inventor
Silvia Buervenich
Lars Olson
Maria Anvret
Andrea Carmine
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE343632T1 publication Critical patent/ATE343632T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Amplifiers (AREA)
  • Soil Working Implements (AREA)
AT00946672T 1999-06-30 2000-06-29 Mutiertes nurr1 gen ATE343632T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902489A SE9902489D0 (sv) 1999-06-30 1999-06-30 Mutated Nurr1 gene

Publications (1)

Publication Number Publication Date
ATE343632T1 true ATE343632T1 (de) 2006-11-15

Family

ID=20416309

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00946672T ATE343632T1 (de) 1999-06-30 2000-06-29 Mutiertes nurr1 gen

Country Status (7)

Country Link
EP (1) EP1194537B1 (de)
AT (1) ATE343632T1 (de)
AU (1) AU6039400A (de)
DE (1) DE60031539T2 (de)
ES (1) ES2273709T3 (de)
SE (1) SE9902489D0 (de)
WO (1) WO2001000807A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005284693B2 (en) * 2004-09-16 2010-04-29 Paul Michael Shillington Centralised online ordering and fulfilment method and system
US8121858B2 (en) 2008-03-24 2012-02-21 International Business Machines Corporation Optimizing pharmaceutical treatment plans across multiple dimensions
US10318877B2 (en) 2010-10-19 2019-06-11 International Business Machines Corporation Cohort-based prediction of a future event

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783680A (en) * 1993-10-06 1998-07-21 The General Hospital Corporation Genetic diagnosis and treatment for impulsive aggression

Also Published As

Publication number Publication date
WO2001000807A1 (en) 2001-01-04
EP1194537A1 (de) 2002-04-10
SE9902489D0 (sv) 1999-06-30
DE60031539D1 (de) 2006-12-07
WO2001000807A8 (en) 2001-04-19
AU6039400A (en) 2001-01-31
EP1194537B1 (de) 2006-10-25
DE60031539T2 (de) 2007-06-21
ES2273709T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
Venkatesh et al. D evelopmental C hromatin R estriction of P ro‐G rowth G ene N etworks A cts as an E pigenetic B arrier to A xon R egeneration in C ortical N eurons
MXPA05014215A (es) Mapeo de genoma de elementos funcionales de adn y proteinas celulares.
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
ECSP088262A (es) Proteínas de fusión de albúmina
ATE361067T1 (de) Naphtoquinone derivate als inhibitoren von tau aggregation zur behandlung von alzheimer's und verbundenen neurodegenerativen erkrankungen
NO974964L (no) Genetiske sekvenser og proteiner som er relatert til Alzheimer's sykdom, og anvendelser av disse
AU2003219085A1 (en) Methods for diagnosing and treating schizophrenia
Hatada et al. Identification of a new imprinted gene, Rian, on mouse chromosome 12 by fluorescent differential display screening
CY1113145T1 (el) Μορια υποδοχεα θυμικης στρωματικης λεμφοποιητινης και χρησεις αυτων
ATE335086T1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten
WO2002031134A3 (en) Novel serine protease genes related to dppiv
ATE540129T1 (de) Target zur therapie kognitiver behinderungen
DK1473367T3 (da) Midler og fremgangsmåder til diagnosticering og behandling af effektive lidelser
EP1565582A4 (de) Verfahren zur identifizierung des brustkrebsrisikos und behandlungen davon
DE60109430D1 (de) An entzündlichen darmerkrankungen beteiligte gene und deren verwendung
NO20015247L (no) Glysinspaltingssysteminhibitorer som potensielle antipsykotika
DK1373502T3 (da) Dopaminerge neuronale overlevelsesfremmende faktorer og avendelser heraf
DE69433243D1 (de) Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit
DE60129069D1 (de) Hepatitis B Virus Vektoren für Gentherapie
ATE343632T1 (de) Mutiertes nurr1 gen
EA200300246A1 (ru) Ген и белок, ассоциированные с шизофренией
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
ATE513033T1 (de) Expression von proteinen in aus nabelschnurblut gewonnenen endothelzellen
NO20021147L (no) Polymorfismer i det humane hPXR genet og bruk av disse i diagnostiske og terapeutiske anvendelser
SE0301987D0 (sv) New polypeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties